S&P 500
5.187,67 -0,03 (-0,00%) Nasdaq
16.302,76 -29,80 (-0,18%) NIKKEI 225
38.202,37 -632,73 (-1,63%) Dólar/Euro
1,0750 -0,0008 (-0,08%) Petróleo Brent
83,78 +0,62 (+0,75%) Bitcoin EUR
57.300,69 -1.333,18 (-2,27%)
LENSAR, Inc. (LNSR)
Después del cierre:
LENSAR, Inc.
2800 Discovery Drive
Orlando, FL 32826
United States
888 536 7271
https://www.lensar.com
Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 130
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Nicholas T. Curtis | President, CEO & Director | 974,29k | N/A | 1957 |
| Mr. Thomas R. Staab II, CPA | CFO & Secretary | 612,55k | N/A | 1968 |
| Mr. Alan B. Connaughton | Chief Operating Officer | 650,62k | N/A | 1972 |
| Ms. Kendra W. Wong | Principal Accounting Officer | N/A | N/A | 1980 |
Descripción
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Gobierno corporativo
El ISS Governance QualityScore de LENSAR, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
